146 related articles for article (PubMed ID: 23278166)
21. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
22. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
[TBL] [Abstract][Full Text] [Related]
23. [Contribution of the cryosurgery in the management of xeroderma pigmentosum].
Zghal M; Triki S; Elloumi-Jellouli A; Jbali A; Gargouri H; Benmously R; Souissi R; Chedly I; Brahim EB; Ayed MB; Fenniche S; Mokhtar I
Ann Dermatol Venereol; 2010 Oct; 137(10):605-9. PubMed ID: 20932439
[TBL] [Abstract][Full Text] [Related]
24. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
25. A case of melanoma in xeroderma pigmentosum.
Rao TN; Bhagyalaxmi A; Ahmed K; Mohana Rao TS; Venkatachalam K
Indian J Pathol Microbiol; 2009; 52(4):524-6. PubMed ID: 19805962
[TBL] [Abstract][Full Text] [Related]
26. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
27. Xeroderma pigmentosum in an African-American.
Orosco RK; Wang T; Byrne PJ
ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):162-5. PubMed ID: 21577039
[TBL] [Abstract][Full Text] [Related]
28. Xeroderma pigmentosum: a review and case series.
Butt FM; Moshi JR; Owibingire S; Chindia ML
J Craniomaxillofac Surg; 2010 Oct; 38(7):534-7. PubMed ID: 20346687
[TBL] [Abstract][Full Text] [Related]
29. [Multiple facial squamous cell carcinomas in a child, revealing a xeroderma pigmentosum].
Beogo R; Andonaba JB; Bouletreau P; Traore Sawadogo H; Traore A
Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):50-2. PubMed ID: 22056175
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
31. [Xeroderma pigmentosum and related syndromes].
Berneburg M; Krutmann J
Hautarzt; 2003 Jan; 54(1):33-40. PubMed ID: 12567255
[TBL] [Abstract][Full Text] [Related]
32. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
Kondo S; Satoh Y; Kuroki T
Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
[TBL] [Abstract][Full Text] [Related]
33. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
34. [Melanoma in xeroderma pigmentosum: 12 cases].
Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
[TBL] [Abstract][Full Text] [Related]
35. Association of xeroderma pigmentosum with thrombasthenia.
Hasanoğlu A; Gücüyener K; Tümer L; Gürsel T
Turk J Pediatr; 1996; 38(2):261-4. PubMed ID: 8701496
[TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
El-Hawary AK; Yassin E; Khater A; Abdelgaber S
Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract][Full Text] [Related]
38. Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review.
Baskurt D; Vural S; Ertekin SS; Baykal C
Int J Dermatol; 2024 Jan; 63(1):59-72. PubMed ID: 37964400
[TBL] [Abstract][Full Text] [Related]
39. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
40. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
